Sangeeta Tiwari

Title: Innovations of Sangeeta Tiwari in Tuberculosis Research

Introduction

Sangeeta Tiwari is a prominent inventor based in the Bronx, NY (US). She has made significant contributions to the field of tuberculosis research, focusing on innovative methods for vaccine efficacy and treatment.

Latest Patents

Sangeeta Tiwari holds 2 patents, with her latest inventions being centered around double auxotrophic mycobacterium. One of her patents describes methods for determining the efficacy of a candidate tuberculosis vaccine and small organic molecule treatments. This involves administering the candidate treatments to an animal infected with an auxotrophic mycobacterium, which has specific genes deleted to enhance the study of treatment efficacy. Another patent provides attenuated strains of BCG, which are double auxotrophic mutants with genes knocked out in the biosynthetic pathways for arginine and methionine, along with methods of use.

Career Highlights

Sangeeta Tiwari is affiliated with the Albert Einstein College of Medicine, where she conducts her research and develops her innovative solutions for tuberculosis treatment. Her work is crucial in the ongoing battle against this infectious disease.

Collaborations

Sangeeta collaborates with notable researchers, including William R Jacobs, Jr., to advance her research and develop effective treatments.

Conclusion

Sangeeta Tiwari's contributions to tuberculosis research through her innovative patents and collaborations highlight her role as a key inventor in the field. Her work continues to pave the way for advancements in medical treatments and vaccine development.